Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 51.04 million as of October 8, 2025. Its market cap has increased by 29.01% in one year.

Market Cap

51.04M

Enterprise Value

41.94M

Revenue

31.34M

Ranking

n/a

PE Ratio

9.31

Stock Price

4.00

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 51.04M, an increase of 242.81%. That is a compound annual growth rate of 7.60%.

Market Cap History

Date	Market Cap	% Change
Oct 8, 2025	51.04M	4.28%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	35.35M	-1.04%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Palestine Telecommunications Company P.L.C	637.07M
Palestine Development & Investment Co.	338.16M
Bank of Palestine	297.12M
Arab Palestinian Investment Company	213.19M
Wataniya Palestine Mobile Telecommunication - Public Shareholding Company	203.47M
Arkaan Real Estate P.L.C	177.25M
The National Bank	124.25M
Quds Bank	103.14M

Market Cap Rankings